Prospective Evaluation of Whole-Body Cancer Screening With Multiple Modalities Including [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography in a Healthy Population: A Preliminary Report

Abstract

While FDG-PET alone is insufficient, whole-body cancer screening with selected modalities including FDG-PET has initial performance supporting possible utility by detecting a wide variety of early-stage cancers with reasonable sensitivity. However, the detection of many indolent cancers and false positives necessitate continuing study for appropriate evaluation.